ABSTRACT
Hantaviruses are zoonotic category-A pathogens that cause highly fatal diseases in humans. The hantaviral genome encodes three viral proteins: RNA-dependent RNA polymerase (RdRp or L protein), nucleocapsid protein (N), and a glycoprotein precursor (GPC), which is posttranslationally cleaved into two surface glycoproteins Gn and Gc. The cytoplasmic tail of Gn interferes with interferon signaling pathways. N is a multifunctional molecule that was shown to be involved in the transcription and translation of viral proteins. N binds to the host mRNA caps and protects the degradation of mRNA 5' termini, which are later snatched and used as primers by the viral RdRp during transcription initiation. N also seems to lure the host translation machinery for the preferential translation of viral transcripts. Moreover, N was shown to delay the induction of cellular apoptosis and facilitate the transport and localization of viral ribonucleoproteins (RNPs) by exploiting the cellular cytoskeleton and SUMOlyation machinery. Therefore, with their limited protein coding capacity, hantaviruses have evolved several strategies to modulate cellular pathways for their efficient replication.
INTRODUCTION
Hantaviruses are zoonotic emerging viruses that are classified as category A pathogens by the Centers for Disease Control and Prevention (CDC). They belong to the family Bunyaviridae, which contains five genera: Hantavirus, Nairovirus, Orthobunyavirus, Phlebovirus and Tospovirus (1) . Unlike all other members of the family, hantaviruses are not transmitted by biting insects. Human infection occurs by inhalation of dust contaminated by droppings, urine or saliva from infected rodents (2) . These viruses establish persistent asymptomatic infection in the rodent host reservoir (3) . Human-to-human transmission is very rare and has been reported in a single outbreak in Argentina (4) .
Hantaviruses cause two serious disease conditions in humans: hemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS), with mortality rates of up to 15% and 50%, respectively. Both syndromes are characterized by capillary leakage and increased permeability of vascular endothelial cells, which is believed to be the result of an immense uncontrolled immune response to infection rather Electron micrograph was obtained from the CDC website with permission (http://www.cdc.gov/ncidod/diseases/hanta/hps/noframes/hpsem.htm). This electron micrograph was also reported in our previous publication (14) . than direct cytopathic effects caused the virus replication in infected cells. Patients develop flu-like symptoms followed by hemorrhage, pulmonary edema, shortness of breath and death from respiratory failure and cardiac insufficiency (5) . Depending on their potential to cause a disease in humans, hantaviruses are classified into pathogenic or nonpathogenic. Examples of non-pathogenic hanatviruses include Prospect Hill (PHV) and Tula virus (TULV). According to their geographic distribution, pathogenic hantaviruses are further classified into two groups Old and New World. Old World hantaviruses, such as Hantaan virus (HTNV), Seoul virus (SEOV), Dobrava virus (DOBV) and Puumala virus (PUUV), are widely distributed in Europe and Asia. On the other hand, New World hantaviruses, such as Sin Nombre virus (SNV), New York-1 virus (NYV) and Andes virus (ANDV) are confined to North and South America. SNV infects deer mouse and is the major cause of HCPS in North America (6) . It was first discovered during a major outbreak that occurred in 1993 in the Four Corners region of the US (the point where Colorado, Arizona, Utah, and New Mexico meet). This outbreak claimed the lives of many victims; about one in three people diagnosed with HCPS died (7) (8) . At present, there is no effective vaccine or antiviral therapy available to treat hantavirus infections.
Hantaviruses have a negative-sense segmented RNA genome that consists of three segments: small (S), medium (M) and large (L) (Figure 1 ). All three segments have non-coding untranslated regions (UTR) at their 5' and 3' termini, which carry partially complementary sequences that fold into panhandle structures (9) (10). Panhandles have been reported to serve as promoters for transcription initiation by the viral L protein. The S segment encodes a nucleocapsid protein (N). In addition to N, the S segment of hantaviruses, carried by the Cricetidae family of rodents, have an overlapping open reading frame (ORF) that codes for the putative nonstructural protein (NSs) (11) (12) . The M segment encodes a glycoprotein precursor (GPC) that is proteolytically cleaved after a highly conserved pentapeptide motif WAASA, into two envelope proteins: Gn and Gc. The L segment encodes the viral RdRp (L protein). N is the main structural protein and plays several important roles in viral assembly, transcription and translation. Gn and Gc mediate the attachment of virus particles to host cell receptors during viral entry into host cells. The cytoplasmic tail (CT) of Gn plays an important role in packaging and has been proposed to be an important viral virulence factor due to its role in blocking the host innate immune responses (13) . L protein is the viral replicase and transcriptase, which uses the negative-sense genome as a template for the synthesis of positive sense complementary RNA (cRNA) and messenger RNA (mRNA) (14) . After attachment, hantaviruses are internalized into target endothelial cells by receptor-mediated endocytosis (15) . Virions are then delivered to lysosomes, where the acidic environment facilitates fusion between viral and cellular lipid membranes, releasing viral nucleocapsids into the cytoplasm. The viral L protein generates three mRNAs from the three viral genome segments, which upon translation produce the four viral proteins. Later in the replication cycle, the virus switches to the genome-copying mode where cRNAs are used as templates for producing negative-sense genomic viral RNAs (12) . N is an RNA-binding protein that undergoes trimerization and oligomerization. The trimeric form of N binds specifically to viral RNA panhandle (16) . N-panhandle interaction has been proposed to play a role in selective encapsidation and packaging of the viral genome (17) . N also interacts with the cytoplasmic tail domain of Gn, which has been proposed to mediate the selective packaging of virion RNPs (18) . Newly formed virions bud off the cell and infect new cells. During this complex replication cycle, hantaviruses control important cellular functions for efficient replication in host cells. In this review, we cover the main elegant strategies that hantaviruses have evolved to modulate basic cellular pathways for their efficient replication (Figure 2 ). To the best of our knowledge, we have tried to cover all the published data in this review; any author's contribution that was left out is totally unintentional. Induction of type I IFN-α/β by the binding of specific PAMPs to TLRs, RIG-I, and MDA-5 engage multiple signal transduction pathways that all converge at the activation of TNF receptor-associated factor 3 (TRAF3). TRAF3 connects the upstream sensory responses to downstream effector functions by forming a complex with and activating a group of kinases: TRAF family member-associated NF-κB activator binding kinase 1 (TBK-1) and IκB kinase ε (IKKε). Ultimately, these kinases phosphorylate and activate two key transcription factors: IFN-regulatory factor-3 (IRF-3) and nuclear factor κB (NFκB) that translocate to the nucleus, where they bind to IFN-stimulated response elements (ISREs) resulting in the expression of type I IFNs (22) .
MODULATION OF THE INNATE IMMUNE RESPONSE
Secreted IFNs bind to cell surface receptors and activate cells in an autocrine and paracrine manner via Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathways. This leads to the expression of a diverse group of more than 300 IFNstimulated genes (ISGs), such as 2',5'-oligoadenylate synthetase (OAS)/RNase L, dsRNA-activated protein kinase (PKR) and orthomyxovirus resistance gene 1 (MxA), which constitute an antiviral state by disrupting viral transcription and translation (23) (24) . The OAS/RNase L is a powerful endoribonuclease system that inhibits broad range of RNA viruses by cleaving singlestranded RNA. PKR is a serine/threonine kinase that induces shut down of host cell translation by phosphorylating the protein synthesis initiation factor eIF2α. Mx proteins are large GTPases that were originally identified because they conferred resistance of the mouse strain A2G to influenza A viruses (25). In vitro, the MxA protein has been shown to inhibit the growth of hantaviruses and other members of the Bunyaviridae family (26) (27) (28).
Hantaviruses have been shown to induce IFN-β production in human endothelial cells, and antibodies to IFN-β inhibited the induction of ISGs and enhanced HTNV replication (29) . However, the PRR responsible for hantavirus recognition remains elusive (30) (31) (32) . Escaping the early innate IFN response is crucial for virus survival. Many viruses have evolved elegant strategies to block the activation of the IFN response allowing the virus to win some time to establish a productive infection in the host (33) . Several reports have indicated that pathogenic hantaviruses delay the induction of IFN response and modulate the innate immune response differently than their non-pathogenic counterparts (13) . DNA microarrays have shown that PHV infection of human umbilical vein endothelial cells (HUVEC) resulted in an early strong IFN response one day post-infection, which was absent following infection with HTNV or NYV (34) . Also, the kinetics of expression of the antiviral protein MxA were different upon TULV and HTNV infection of HUVEC cells. TULV infection resulted in rapid induction of MxA (16 h post-infection), whereas HTNV induced MxA relatively late (48 h post-infection). Accordingly, TULV titers were much lower than HTNV in HUVEC cells. However, both viruses replicated equally well in African green monkey kidney (Vero E6) cells, which lack INF genes (35) . In infected HUVEC cells, PHV RNA and protein synthesis were shown to be restricted to the first day post-infection, and then dropped dramatically 2 -5 days post-infection. This was in direct contrast to HTNV and NYV, which continued to synthesize viral mRNA and protein 1 -5 days post-infection (36) . These findings have suggested that differences in INF responses may account for the pathogenic potential of hantaviruses. Pathogenic, but not non-pathogenic hantaviruses are able to delay early IFN responses to allow efficient viral replication. Moreover, these differential IFN responses have clearly indicated that some proteins encoded by pathogenic hantaviruses are capable of regulating the early innate immune responses. Indeed, IFN antagonists have been identified in several Old and New World hantaviruses; and the ability of hanatviruses to inhibit IFN induction has been mapped to three viral proteins: Gn, NSs and N.
Cytoplasmic tail of Gn protein
In contrast to N and Gc proteins, Gn is expressed very poorly in infected and transfected cells (37) . Gn of hantaviruses contains a long cytoplasmic tail (CT) (142 amino acid residues) that has been proposed to be a virulence factor that contributes to hantavirus pathogenesis. Geimonen and colleagues identified key signaling elements termed immunoreceptor tyrosine-based activation motifs (ITAMs) within the Gn CT of all HPS-causing hantaviruses, but not HFRS or non-pathogenic hantaviruses (38) . ITAM motifs consist of two tandem Yxx(L/I) sequences and were originally identified in the CTs of Band T-cell receptors (BCR and TCR). Upon ligand binding, they recruit Src and Syk family kinases to convey signals to the intracellular signaling pathways (39) . Two-hybrid analysis revealed that the tyrosine residues of NYV Gn ITAMs interacted with Src and Syk family kinases in a manner similar to the ITAMs of BCR and TCR. The fact that these ITAMs were conserved in all HPS-causing hantaviruses strongly suggested a direct role for the Gn tail in modulating immune and endothelial cell functions by altering normal cell signaling responses. It was also shown that the CT of NYV Gn is polyubiquitinated and targeted for proteosmal degradation. Mutational analysis revealed that the tyrosine residues of the ITAM motif were responsible for this interaction (40) . The signal for degradation was later mapped to the C-terminal 30 residues of the pathogenic ANDV and HTNV Gn CTs. Moreover, it was reported that the CT of the non-pathogenic PHV is stable and not proteosomally degraded in Vero E6 and COS-7 cells (41) . These findings have suggested that there is a direct link between CT degradation and pathogenesis. Later, Wang and colleagues showed that the Gn CTs of the non-pathogenic TULV and PHV were proteosomally degraded in Human Embryonic Kidney (HEK-293) and Vero E6 cells (42) . This conflicting evidence suggested that this degradation might not be necessarily related to viral pathogenesis. However, additional reports showed that the CTs of pathogenic, but not non-pathogenic hantaviruses regulate IFN activation signaling pathways. Expression of the NYV CT, but not the PHV CT, inhibited TBK-1-directed IFN induction by disrupting the formation of TBK1-TRAF3 complexes and the downstream signaling responses required for IFN-β transcription (36) (43).
Non-structural protein (NSs)
Three out of the five genera of the Bunyaviridae family (Orthobunyavirus, Phlebovirus and Tospovirus) are known to encode a nonstructural protein (NSs) in their S segment as an overlapping reading frame to the ORF of N (12). In Phlebo-and Tospoviruses, the NSs protein is encoded by the (+) strand of the S segment RNA, i.e., an ambi-sense coding strategy is employed. The presence of an overlapping NSs protein was described for at least 16 distinct hantaviruses (11) . The NSs encoded by some of these viruses, such as Bunyamwera virus (BUNV) and Rift Valley Fever virus (RVFV), have been associated with IFN antagonizing functions (44) (45). Members of the other two genera (Hantavirus and Nairovirus) are generally not known to encode NSs. However, overlapping reading frames corresponding to the NSs have been identified in SNV, TULV, PUUV and PHV. More recently, a protein corresponding to the predicted size of TULV NSs was detected using coupled in vitro transcription and translation reactions, and a protein corresponding to the predicted size of PUUV NSs was also detected in infected cells by western blotting (46) . In reporter-based systems, transiently expressed TULV and PUUV NSs in COS-7 cells had weak inhibitory effects on the activities of IFN-β promoter, and NF-kB and IRF-3 responsive promoters. These findings have suggested that hantavirus NSs is also a weak IFN antagonist, however the mechanism of this anti-IFN activity is not known (46).
Nucleocapsid protein (N)
Some studies have suggested that hantavirus N is a potential IFN-β antagonist. As will be explained later in this review, HTNV N was shown to interfere with NF-κB nuclear transport by binding to importin-α (47) (48). A similar activity was also reported for SEOV and DOBV (49) . For ANDV, it was shown that co-expression of both GPC and N is required for inhibition of INF-β induction and signaling. Expression of ANDV N alone resulted in 50% inhibition of STAT-1 phosphorylation and of JAK/STAT-dependent promoter activity (50).
MODULATION OF THE HOST mRNA DEGRADATION PATHWAYS FOR CAP SNATCHING AND TRANSCRIPTION INITIATION:
The genome of segmented negative-stranded RNA viruses (Orthomyxoviridae, Arenaviridae and Bunyaviridae) is made up of negative-sense RNA strands. In order for this genome to be replicated, it has to be first converted into a positive-sense strand that can serve as a template for the production of viral RNA. The viral L protein cannot initiate this transcription process de novo, and therefore requires a primer (51) . Mature cellular messenger RNAs (mRNAs) have a 5' methylated cap and a 3' poly (A) tail. Early studies on influenza virus have shown that viral mRNAs were polyadenylated and contained heterogenous non-viral cap sequences at the 5' end (52) (53) . Further work revealed that those caps were derived from the 5' termini of cellular mRNAs and led to the development of the concept of "cap snatching". Cap snatching is a unique mechanism used by negative-stranded RNA viruses to generate shortcapped RNA primers from host cell mRNAs that are used for transcription initiation by the viral L protein. This mechanism has been well characterized for influenza virus. In this process, the influenza virus polymerase binds to the m7G cap of nuclear pre-mRNAs and cleaves them 10 -15 nucleotides downstream the terminal cap. The resulting RNA oligonucleotides are used as primers to initiate transcription from the viral RNAs, resulting in the generation of capped and polyadenylated mRNAs that resemble the host cell messages. Viral mRNAs are then exported from the nucleus to the cytoplasm for translation (54) (55) . Influenza virus RdRp is made up of three viral proteins: polymerase acidic protein (PA), polymerase basic protein 1 (PB1), polymerase basic protein 2 (PB2) (56) . The cap-binding domain of influenza virus was mapped to the central region of the PB2 subunit. The endonuclease activity was shown to reside in the N-terminal region of the PA subunit. PB1 has intrinsic polymerase activity and is responsible for mRNA elongation (57) (58) (59).
A similar cap snatching mechanism was proposed for the viruses of the Bunyaviridae and Arenaviridae families (60) (61) (62), although their RdRps are structurally different (14) . Based on the precedent with influenza virus, it has been assumed that the endonuclease activity required for cap snatching resides in the RdRp of Bunyaviruses and Arenaviruses. Recent biochemical and structural data from the RdRp of La Crosse orthobunyavirus (LACV) showed that it has a functional, manganese-dependent N-terminal endonuclease domain (180 residues) that has very similar characteristics to that of influenza virus endonuclease (63) . Similarly, the NL1 domain (N-terminal 196 residues) of the RdRp from the prototypic arenavirus, lymphocytic choriomeningitis virus (LCMV), was shown to bind and cleave RNA (64) . Using a structure-based sequence alignments approach, (63) the existence of a similar endonuclease domain at the Nterminus of the RdRps of all known segmented negativestranded RNA viruses was predicted.
In contrast to influenza virus, which replicates in the nucleus, bunya-and arenavirus replication is exclusively cytoplasmic, and therefore caps are derived from cellular mRNAs rather than pre-mRNA (51). Since cellular mRNA degradation also occurs in the cytoplasm, this raised the question of the relationship between mRNA decay pathways and the bunya-and arenavirus capsnatching process. Indeed, we have shown that Sin Nombre hantavirus N colocalized with the discrete cytoplasmic processing bodies (P-bodies), where cellular mRNA decay is known to occur (65) . Each P body can be envisioned as an extensive network of RNA and RNA binding proteins, comprised of decapping enzymes associated with the mRNA degradation machinery and translation repression. In addition to their role in mRNA degradation, P bodies can also serve as cellular temporal storage sites for mRNAs that can later return and resume translation (66) (67) . In eukaryotic cells, two mRNA decay pathways have been identified, both of which begin with removing the 3′ poly (A) tail in a process referred to as deadenylation. Following deadenylation, mRNAs can be degraded in a 3′ to 5′ direction by an exonuclease complex termed the exosome. Alternatively, the mRNA can be decapped by the DCP1/DCP2 decapping enzyme, rendering the mRNA susceptible to 5′ to 3′ degradation by the exonuclease XRN1 (68) . Interestingly, we have demonstrated an important role for SNV N in cap snatching (65) . N was shown to bind and protect the 5' caps of cellular mRNAs from degradation and store them in the P-bodies. This pool of sequestered capped oligoribonucleotides in P-bodies is later used as primers by the viral L protein during transcription initiation. Moreover, it was shown that SNV N has distinct cap-and RNA-binding sites (69) . N undergoes a conformational change upon binding of the capped RNA primer at the cap-binding site. It was suggested that the conformationally altered N with a capped primer loaded at the cap-binding site binds specifically to the conserved 3′ nine nucleotides of viral RNA and assists the bound primer to anneal at the 3′ terminus, therefore facilitating transcription initiation (69).
MODULATION OF THE HOST CELL TRANSLATION MACHINERY
The mRNAs in eukaryotic cells carry 7-methylguanosine (m7G) cap at their 5' ends. Translation of these capped mRNAs is a complex process and is initiated with the recruitment of eIF4F cap binding complex at the 5' cap, followed by loading of the 43S-preinitiation ribosome complex at the cap with the assistance of the eIF4F complex. The eIF4F complex is an amalgam of three initiation factors: eIF4E (cap binding protein), eIF4A (DEAD box RNA helicase that dissociates the secondary structures at the 5' UTR of mRNA) and eIF4G (linking peptide that stabilizes the ribosome at the 5' mRNA cap via interaction with eIF3 (70) (71) . The 43S pre-initiation complex contains the eukaryotic initiation factors 3, 1, 1A, 5 and a ternary complex composed of methionine-loaded initiator tRNA and eIF2 coupled with GTP. Recruitment of the 43S complex to capped mRNA by the cap-binding complex enables subsequent scanning of the mRNA from the 5' end, and when a start AUG codon is encountered, the 60S large ribosomal subunit is recruited and translation begins (72) .
Viruses rely on the host cell translation machinery for the translation of their own mRNAs. Confronted by the tough competition with cellular mRNAs for the same translation apparatus, viruses have evolved several strategies to hijack the cellular translation machinery (73) . Some viruses, such as picornaviruses and flaviviruses, shut down host but not viral mRNA translation. These viruses have evolved a cap-independent mechanism of translation that is mediated by an internal ribosome entry site (IRES), which is a cis-acting RNA high-order structural elements in the 5′ UTR of the viral mRNA, and is capable of recruiting ribosomes without the need for the eIF4F cap-binding complex or some of its components (74) (75) (76).
Hantaviruses have evolved a unique translation mechanism operated by the viral N protein, that lures the host translation machinery for the preferential translation of viral transcripts. N is a surrogate of the entire eIF4F capbinding complex, and therefore functions as a multifunctional translation initiation factor. N also binds to the ribosomal protein S19 (RPS19), located at the head region of the 40S ribosomal subunit, and subsequently helps recruiting the 43S pre-initiation complex at the mRNA cap (77) (78) (79). We have shown that N augments translation of both viral and non-viral mRNA. However, competitive translation reactions containing both viral and non-viral mRNA revealed that the translation of mRNA containing the viral mRNA 5' UTR was more robust compared to mRNA containing non-viral leader sequence. Mutational analysis of the viral mRNA 5'UTR revealed that the sequence "GUAGUAG" of the triplet repeat motif was sufficient for preferential N-mediated translation initiation and for high-affinity binding of N to the UTR (80).
MODULATION OF THE CYTOSKELETAL PROTEINS FOR PROPER TRAFFICKING AND ASSEMBLY
The cellular cytoskeleton is composed of a complex network of three types of filaments: actin microfilaments, microtubules and intermediate filaments. The cytoskeleton serves many key structural functions in the biology of the cell, including: providing mechanical strength, motility, organelle anchoring and intracellular transport (81) . The host cytoskeleton also plays important roles in the life cycle of many viruses. Due to the complexity of the cellular interior, the movement of virions, subviral particles and viral proteins within the cell cannot simply rely on passive diffusion. Therefore, cytoplasmic transport of viral cargos is an active process that is mediated by interactions between the cytoskeletal filaments and motor proteins. Three classes of cytoskeletal motor proteins are known: myosin, which interacts with actin microfilaments, and two types of microtubule-interacting motors, kinesin and dynein. In order for these motors to perform their mechanical function, which is binding to cytoskeletal filaments and moving cargos along them, they use energy derived from ATP hydrolysis (82) (83) . Viruses exploit the host cytoskeleton and their motors to move on microtubules toward the cell interior during entry and to move assembling virus particles toward the cells membrane during egress. Many viruses interact with actin at different stages during their replication cycle, both disrupting and rearranging the actin cytoskeleton to their own advantages (84) (85) (86) .
In contrast to the majority of enveloped viruses that mature by budding from the plasma membrane, many members of the Bunyaviridae family, especially Old World hantaviruses, were shown to bud into the lumen of the Golgi complex. Progeny virions are then released by fusion of secretory vesicles with the plasma membrane (87) (12). However, it was suggested that the assembly of New World hantaviruses [e.g. SNV and Black Creek Canal virus (BCCV)] might occur at the plasma membrane (88) . Several reports have pointed out that the components of the microtubule and actin cytoskeleton are essential for the replication and morphongenesis of both Old and New World hantaviruses (89) (90) (91) (91) . The ERGIC constitutes an independent structure that is not continuous with the ER or the Golgi compartment. ERGIC is maintained by a continuous flow of membranes mediated by motor proteins, dynein and kinesin, which transport cargo bi-directionally to the ER and to the Golgi compartment (93) . Treatment of HTNV-infected cells with nocodazole (NOC), a microtubuledepolymerizing agent, caused rapid distribution of N and decreased levels of HTNV S segment vRNA. Over-expression of dynamitin, a dominant-negative form of dynien, which blocks transport on microtubules reduced N accumulation in the perinuclear region. These results suggested that microtubules are essential for the intracellular N transport and viral RNA replication of HTNV. These results also implied that N traffics to the ERGIC prior to its movement to the Golgi compartment, and an intact ERGIC is essential for virus replication. Ramanathan and Jonsson have further extended those studies to another Old World hantavirus, SEOV, and two additional New World hantaviruses, ANDV and BCCV (92) . The N protein of all of these viruses also colocalized with the ERGIC. However, distinct differences in cytoskeletal requirements for replication were detected. Immunofluorescence studies showed clear association of ANDV N protein with actin in the perinuclear region and ANDV replication was found to be sensitive to Cyt D. HTNV and SEOV were sensitive to NOC. However, BCCV's replication was affected by both Cyt D and NOC. These findings indicated that Old and New World hantaviruses share common features, but they have evolved differences in their interaction with host cytoskeletal machinery.
MODULATION OF THE APOPTOSIS SIGNALING PATHWAYS
Hantaviruses replicate in the cytoplasm of endothelial cells and several mammalian cell lines without causing any pronounced cytopathic effect. However, several studies have suggested that Old and New World hantaviruses (HTNV, ANDV, SEOV, TULV and PUUV) induce apoptosis (94) (95) (96) (97) (98) . The role of apoptosis in the hantavirus life cycle and the viral protein responsible for its induction are poorly understood. The ability of viruses to regulate the induction of cellular apoptosis during infection is critical for viral survival. Several studies have suggested that hantaviruses use some unique approaches to block apoptosis, and therefore enhance its ability to replicate in infected cells.
Daxx is a well-known Fas-mediated apoptosis enhancer, which transduces death signals through the Jun N-terminal kinase (JNK) pathway (99) . Yeast two-hybrid screening of a cDNA library from Hela cells has revealed that PUUV N interacts with Daxx (100). This interaction was further confirmed by GST pull-down assay, coimmunoprecipitation and co-localization studies. It was suggested that binding of N to Daxx might interfere with its functions, and therefore delay apoptosis (101) .
Another strategy used by hantaviruses to block apoptosis is via sequestering the NF-κB in the cytoplasm, and thus inhibiting its activity. NF-κB is a transcription factor that plays a key role in initiating the host antiviral signaling and apoptotic response. It is activated by inflammatory cytokines, such as tumor necrosis factor-α (TNF-α), through the TNF receptor family. Normally, NF-κB is sequestered in the cytoplasm by IκB, which masks its nuclear localization signal (NLS). Upon its activation, NF-κB translocates to the nucleus and serves as a transcription factor for a number of genes that are mainly associated with triggering both the host innate and adaptive immune responses (102) (103) (104) . NF-κB is too large to diffuse through the nuclear pore, therefore it requires a nuclear import system consisting of importin-α and importin-β, which bind to the NLS (105) . Upon TNF receptor stimulation, NF-κB was sequestered in the cytoplasm of HTNV N protein-expressing cells, which showed inhibition of caspase activation. However, cells expressing HTNV N protein truncation mutants lacking the region from amino acids 270 -330, were unable to inhibit the nuclear import of NF-κB. Those mutants has also lost their ability to down-regulate apoptosis. Therefore, it was concluded that HTNV suppresses host apoptotic responses via blocking the trafficking of NF-κB into the nucleus either by binding to it directly or by binding to importin-α molecules responsible for its nuclear shuttling (47) (48).
MODULATION OF THE SUMOYLATION MACHINERY FOR PROPER N SUBCELLULAR LOCALIZATION AND ASSEMBLY
SUMOylation is a post-translational modification that occurs to many cellular and viral proteins. It involves the conjugation of a small protein, known as SUMO (small ubiquitin-related modifier), to the lysine side chain of the target protein via isopeptide bonding. It is a multi-step process that involves four enzymatic reactions. First, SUMO proteins are post-translationally processed by SUMO proteases to expose a C-terminal diglycine motif, which can then form a thioester bond with the catalytic cysteine residue of the E1-activating enzyme, the SAE1/SAE2 (SUMO activating enzyme) heterodimer. This activation step is then followed by conjugation of the activated SUMO to the E2-conjugating enzyme Ubc9 (ubiquitin-conjugating enzyme) through the formation of another thioester bond. Finally, an isopeptide bond is formed between SUMO proteins and the target protein through the mutual action of Ubc9 and E3 SUMO protein ligases (106) (107) (108) . The functional consequences of SUMOylation seem to be substrate-specific, but have generally been implicated in regulating stability, protein-protein interactions and subcellular localization of target proteins (109) .
Viruses have evolved to utilize or subvert the SUMOylation system to their own benefit (110) (120) . The outcome of all of these types of interactions is to modulate the cellular environment to become more favorable for viral replication. Regulation of viral protein subcellular localization and assembly by interaction with components of the SUMOylation machinery has been also reported for other viruses. The E1 protein of papillomavirus is a SUMOylated nuclear protein that is essential for viral genome replication. SUMOylationdeficient E1 mutants were shown to accumulate in the cytoplasm and perinuclear region rather than the nucleus. These results indicate that sumoylation is critical for nuclear accumulation of E1 protein (121) (122). More recently, it was reported that influenza A virus matrix protein (M1) is SUMOylated (115) . Abolishment of M1 SUMOylation resulted in dramatic reduction of the virus titer. Further analysis revealed that the lack of M1 SUMOylation prevented the nuclear export of vRNP, and the subsequent virus assembly and release.
Yeast two-hybrid screening of human cDNA libraries has revealed that HTNV and SEOV N proteins interact not only with SUMO-1 conjugating enzyme (Ubc9), but also with the SUMO-1-interacting proteins PIAS1, PIASxβ, HIPK2, CHD3, and TTRAP (117) (123) . Analysis of the interaction between truncated N proteins and Ubc9 revealed that the amino acid residues 101 -238 of HTNV and 100 -125 of SEOV N proteins were responsible for this interaction. Further yeast two-hybrid screening of host proteins revealed that TULV N protein also interacts with SUMO-1 and SUMO-1 conjugating enzyme, Ubc9 (116) . In these studies, the N and SUMO-1 were shown to colocalize at the perinuclear area. The N itself was not found to be SUMOylated both in vivo and in vitro. However, it was possible to correlate between the degree of interaction of truncated N proteins with SUMO-1 or Ubc9 and differences in the localization patterns of the mutants in the cytoplasm. Therefore, it was concluded that the interaction of the N with Ubc9 or SUMO-1 is necessary for the proper subcellular localization of N at the perinuclear region where virus assembly is believed to occur.
CONCLUSION AND FUTURE PERSPECTIVES
We have witnessed over the past few decades the emergence of several viral disease epidemics of zoonotic origins. Hantaviruses have firstly emerged as causes of serious human illness in the early 1950s during the Korean War. However, it was not until 1981 when the causative agent was identified. The second major outbreak, which occurred in the southwestern region of the US in 1993, with its high fatality rate, has alarmed the world's population to the highly pathogenic potential of this group of viruses. Despite several efforts to develop a vaccine or antiviral drug to protect or treat hantavirus infection, an FDA-approved control strategy is still lacking. Progress in hantavirus research was hindered by two major roadblocks, namely the lack of a reliable animal model and reverse genetics system. Understanding the molecular details of hantavirusreplication cycle is of paramount significance for identifying novel targets for inhibiting virus replication. As outlined in this review, although several mechanisms for how hantaviruses exploit cellular machineries and signaling pathways for their own advantage have been identified, more work is needed to define steps that can be interrupted with chemical inhibitors without interrupting major cellular functions. One newly identified promising target for inhibiting hantavirus replication is the N-mediated mechanism of translation initiation. Chemical compounds that can selectively inhibit Nmediated translation mechanism will likely interfere in the translation efficiency of viral mRNAs and consequently inhibit virus replication in infected cells. High-throughput screening of chemical libraries is currently underway to identify positive leads that would set the stage for the development of specific anti-hantavirus drugs.
